In a 3-month human study, Lucidal
produced large and statistically significant improvements in a number of brain functions. These included sustained focus and concentration, attention, memory, learning, how fast we think and improved mood parameters - including mild depression and anxiety.
was studied in a prospective, double-blind, randomized, placebo-controlled human clinical trial performed by independent third party investigators who specialize in the supervision of this type of human experimentation. The study was conducted under the direction of an Institutional Review Board (IRB) that assures volunteers are safely treated. The test results were then published in a peer-reviewed medical journal.
The link to the Lucidal
published paper can be found: Here
- Patent (US 6,964,969)
Composition and Method for Treating impaired or Deteriorating Neurological Function
patent covers a novel nutritional supplement designed to protect brain health and function by incorporating a holistic combination of nutritional ingredients that beneficially modulate an array of physiologic processes that contribute to nerve cell dysfunction.
The neurological pathways regulate inflammation, energy production, free radical generation, cell membrane function, neurotransmitter activity, stress hormone (cortisol) levels, vascular health, nerve growth factors, heavy metal toxicity, methyl metabolism and proper glucose and insulin metabolism.
When the health of nerve cells deteriorates and brain function becomes impaired, multiple metabolic processes are involved. Based on this observation, the patented product Lucidal
is formulated to correct these deteriorating pathways and thus enhance global brain function.